Vericiguat in Heart Failure with Reduced Ejection Fraction REPLY

被引：0
|
作者：
Armstrong, Paul W. [1 ]
Anstrom, Kevin J. [2 ]
O'Connor, Christopher M. [3 ]
机构：
[1] Univ Alberta, Edmonton, AB, Canada
[2] Duke Clin Res Inst, Durham, NC USA
[3] Inova Heart & Vasc Inst, Falls Church, VA USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2020年 / 383卷 / 15期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1497 / 1498
页数：2
相关论文
共 50 条
  • [41] Cost-Utility Analysis of Vericiguat in Heart Failure with Reduced Ejection Fraction After Worsening Heart Failure Events in China
    Chen, Penglei
    Wang, Yixiang
    Liu, Xin
    Yu, Jiaqi
    Zheng, Xuwei
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2024, 24 (03) : 445 - 454
  • [42] Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial
    Pieske, Burkert
    Patel, Mahesh J.
    Westerhout, Cynthia M.
    Anstrom, Kevin J.
    Butler, Javed
    Ezekowitz, Justin
    Hernandez, Adrian F.
    Koglin, Joerg
    Lam, Carolyn S. P.
    Ponikowski, Piotr
    Roessig, Lothar
    Voors, Adriaan A.
    O'Connor, Christopher M.
    Armstrong, Paul W.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 (12) : 1596 - 1604
  • [43] Vericiguat and health status outcomes in heart failure with reduced ejection fraction: insights from the VICTORIA trial
    Butler, J.
    Stebbins, A.
    Melenovsky, V.
    Sweitzer, N.
    Cowie, M. R.
    Stehlik, J.
    Ezekowitz, J. A.
    Hernandez, A. F.
    Lam, C. S. P.
    Nkulikiyinka, R.
    O'Connor, C. M.
    Pieske, B.
    Ponikowski, P.
    Voors, A. A.
    Armstrong, P. W.
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 : 786 - 786
  • [44] Vericiguat in patients with atrial fibrillation and heart failure with reduced ejection fraction: insights from the VICTORIA trial
    Ponikowski, Piotr
    Alemayehu, Wendimagegn
    Oto, Ali
    Bahit, M. Cecilia
    Noori, Ebrahim
    Patel, Mahesh J.
    Butler, Javed
    Ezekowitz, Justin A.
    Hernandez, Adrian F.
    Lam, Carolyn S. P.
    O'Connor, Christopher M.
    Pieske, Burkert
    Roessig, Lothar
    Voors, Adriaan A.
    Westerhout, Cynthia
    Armstrong, Paul W.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (08) : 1300 - 1312
  • [45] Heart failure: Not only reduced left ventricular ejection fraction but also reserved ejection fraction! Reply
    Minasian, Armine G.
    van den Elshout, Frank J. J.
    Dekhuijzen, P. N. Richard
    Vos, Petra J. E.
    Willems, Frank F.
    van den Bergh, Paul J. P. C.
    Heijdra, Yvonne F.
    [J]. HEART & LUNG, 2013, 42 (03): : 229 - 230
  • [46] Ejection Fraction in Heart Failure Reply
    Gaasch, William H.
    Zile, Michael R.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (12): : 1845 - 1845
  • [47] Towards the Fifth Pillar for the Treatment of Heart Failure with Reduced Ejection Fraction: Vericiguat in Older and Complex Patients
    Spadafora, Luigi
    Bernardi, Marco
    Sarto, Gianmarco
    Simeone, Beatrice
    Forte, Maurizio
    D'Ambrosio, Luca
    Betti, Matteo
    D'Amico, Alessandra
    Cammisotto, Vittoria
    Carnevale, Roberto
    Bartimoccia, Simona
    Sabouret, Pierre
    Zoccai, Giuseppe Biondi
    Frati, Giacomo
    Valenti, Valentina
    Sciarretta, Sebastiano
    Rocco, Erica
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2024, : 469 - 479
  • [48] Statins Beneficial for Heart Failure With Preserved Ejection Fraction But Not Heart Failure With Reduced Ejection Fraction?
    Ohte, Nobuyuki
    Little, William C.
    [J]. CIRCULATION JOURNAL, 2015, 79 (03) : 508 - 509
  • [49] Is targeting cyclic guanosine monophosphate by vericiguat effective to treat ischaemic heart failure with reduced ejection fraction? Yes, it is
    Emdin, Michele
    Aimo, Alberto
    Castiglione, Vincenzo
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (05) : 791 - 793
  • [50] Examination of the Suitability of Vericiguat in Non-Heart Failure with Preserved Ejection Fraction Patients with Improved Ejection Fraction
    Kinoshita, Haruyuki
    Sugino, Hiroshi
    Fujita, Kento
    Sumimoto, Yoji
    Masada, Kenji
    Shimonaga, Takashi
    Suga, Akiyo
    Toko, Mayumi
    Taniyasu, Kaori
    Ushirozako, Saki
    Katayama, Yumiko
    Hirahara, Chiemi
    Takada, Masahiro
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (17)
12345